Skip to main content

Advertisement

Table 1 Summary of datasets used to assess priority ranking performance

From: SWIFT-Review: a text-mining workbench for systematic review

Data set Source Database (inputs) Records from search Included Excluded Comments
PFOA/PFOS and immunotoxicity NIEHS PubMed (PMIDs) 6331 95 (1.5 %) 6236 (98.5 %) Targeted topica
Bisphenol A (BPA) and obesity NIEHS PubMed (PMIDs) 7700 111 (1.4 %) 7589 (98.6 %) Targeted topic
Transgenerational inheritance of health effects NIEHS PubMed (PMIDs) 48,638 765 (1.6 %) 47,873 (98.4 %) Untargeted topic
Fluoride and neurotoxicity in animal models NIEHS Multiple (titles + abstracts) 4479 51 (1.1 %) 4428 (98.9 %) Targeted topic
Neuropathic pain CAMARADES Multiple (titles + abstracts) 29,207 5011 (17.2 %) 24,196 (82.8 %) Semi-targeted topic
Skeletal muscle relaxants [6] PubMed (PMIDs) 1643 9 (0.6 %) 1634 (99.4 %) Public dataset
Opioids [6] PubMed (PMIDs) 1915 15 (0.8 %) 1900 (99.2 %) Public dataset
Antihistamines [6] PubMed (PMIDs) 310 16 (5.2 %) 294 (94.8 %) Public dataset
ADHD [6] PubMed (PMIDs) 851 20 (2.4 %) 831 (97.6 %) Public dataset
Triptans [6] PubMed (PMIDs) 671 24 (3.6 %) 647 (96.4 %) Public dataset
Urinary Incontinence [6] PubMed (PMIDs) 327 40 (12.2 %) 287 (87.8 %) Public dataset
Ace Inhibitors [6] PubMed (PMIDs) 2544 41 (1.6 %) 2503 (98.4 %) Public dataset
Nonsteroidal anti-inflammatory [6] PubMed (PMIDs) 393 41 (10.4 %) 352 (89.6 %) Public dataset
Beta blockers [6] PubMed (PMIDs) 2072 42 (2.0 %) 2030 (98.0 %) Public dataset
Proton pump inhibitors [6] PubMed (PMIDs) 1333 51 (3.8 %) 1282 (96.2 %) Public dataset
Estrogens [6] PubMed (PMIDs) 368 80 (21.7 %) 288 (78.3 %) Public dataset
Statins [6] PubMed (PMIDs) 3465 85 (2.5 %) 3380 (97.5 %) Public dataset
Calcium-channel blockers [6] PubMed (PMIDs) 1218 100 (8.2 %) 1118 (91.8 %) Public dataset
Oral hypoglycemics [6] PubMed (PMIDs) 503 136 (27.0 %) 367 (73.0 %) Public dataset
Atypical antipsychotics [6] PubMed (PMIDs) 1120 146 (13.0 %) 974 (87.0 %) Public dataset
  1. aTargeted topics refers to examples where a specific exposure and health outcome were identified (e.g., bisphenol A and obesity); for untargeted topics, one or both of these parameters were not defined, e.g., the topic transgenerational inheritance of health effect focused on a particular study design and was not restricted to a specific type of exposure or health outcome